International Health Regulations 2005

Debate between Christopher Chope and Maria Miller

Monday 18th December 2023 Westminster Hall

[Sir Christopher Chope]

Absolutely; I agree with my right hon. Friend. We do not want to withdraw; there is no need to withdraw from a voluntary organisation that is confined to giving us advice and providing data and information. Who would resent having access to data and information? Indeed, the essence of the relationship between a responsible society and its Government is that the Government should provide information to enable individuals to decide for themselves whether they want to take particular medicines, go on trips to particular countries, be vaccinated in a particular way, or whatever.

I see the proper role of the WHO as providing information to Governments across the globe. Those Governments can then decide for themselves what they like and do not like, having regard to the fact that the WHO’s chairman seems to have been imposed on it by the People’s Republic of China, and was strongly opposed by our Government. It seems very much as though the whole WHO is too beholden to China. The WHO is also beholden to some of its big donors; if one analyses how the WHO is funded, one sees that organisations such as the Bill & Melinda Gates Foundation are significant supporters. He who pays the piper calls the tune. I think that is a good starting point when looking at these things. In the case of the WHO, there is too much evidence that the people paying the piper are calling the tune to too great an extent.

Once bitten, twice shy. Let us remind ourselves what happened during the pandemic. As others have mentioned, the WHO went into the pandemic with a policy of saying that lockdowns were not, and could not be, the right answer to a pandemic for all sorts of reasons. We can now see the adverse consequences that flowed from our country’s decision to have a lockdown, and we can compare that with what happened in Sweden. Then, during the early part of the pandemic discussions, and without any evidence being brought forward, the WHO suddenly changed its advice. Why? There is a suspicion that it was because of undue influence from the pressures that I have been describing. We will never know why it changed its advice. All we know is that somebody who changes their advice like that, without any evidence, should not tell us what to do. We should say, “If you want to change your advice, fine, but why do you change it? We don’t have to follow it.” However, under the proposed treaty amendments, we would have to follow it. That is obviously of great concern, because people can see what happened in the past, and that is potentially a guide to the future.

Even more sinister than the change in advice on lockdowns was the WHO’s approach to finding a treatment for covid-19 patients. There was a lot of evidence to suggest that ivermectin—it was not the only such drug—could be used to really good effect to improve outcomes for patients suffering from covid-19. Strong evidence suggested that treatment with ivermectin might improve someone’s chances of survival by as much as 81%, but the WHO intervened at the behest of certain pharmaceutical companies that were in competition with the producers of ivermectin. It gave very dubious advice, to the effect that ivermectin should be used only in clinical trials.

To those who are not familiar with too much of the detail, I commend a book by Dr Pierre Kory, a distinguished physician and epidemiologist—I think he is an epidemiologist. He certainly deals with pulmonary and critical-care medicine; he is a specialist in that. He was in charge of the Front Line COVID-19 Critical Care Alliance, and produced a book called “The War on Ivermectin”. It was a war, organised by the WHO, against a remedy for covid-19, because, obviously, the whole vaccine development programme was premised on there being no cure for covid-19, and no effective treatment for it. In the absence of such treatment, it was legitimate for experimental vaccines to be brought into play without undergoing the full process set out in the Licensing Act 2003, because there was there was nothing else. We were in the desperate situation of there being no other way out. Actually, however, there was a lot of evidence to suggest that ivermectin—

[Dame Maria Miller (in the Chair)]

Order. I am sure that the hon. Member is not intending to use a prop. Let us leave it to Amazon to sell books.